Filip, S., Bláha, M., Vaňásek, J., Měřička, R., Vávrová, J., & Podzimek, K. The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients.
Citácia podľa Chicago (17th ed.)Filip, Stanislav, M. Bláha, J. Vaňásek, R. Měřička, J. Vávrová, a K. Podzimek. The Increase of the Rate of Hemopoietic Recovery and Clinical Benefit of the Erythropoietin (EPO) and Granulocyte Colony-stimulating Factor (G-CSF) with Peripheral Blood Progenitor Cells (PBPC) After Intensive Cyclic Chemotherapy in High-risk Breast Cancer Patients.
Citácia podľa MLA (8th ed.)Filip, Stanislav, et al. The Increase of the Rate of Hemopoietic Recovery and Clinical Benefit of the Erythropoietin (EPO) and Granulocyte Colony-stimulating Factor (G-CSF) with Peripheral Blood Progenitor Cells (PBPC) After Intensive Cyclic Chemotherapy in High-risk Breast Cancer Patients.
